HomeNDC LookupRxCUI directory › RxCUI 2725946

1.7 ML denosumab-kyqq 70 MG/ML Injection [Aukelso] — RxCUI 2725946

RxNorm drug concept · Semantic branded drug
RxCUI 2725946 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2725946
Official name1.7 ML denosumab-kyqq 70 MG/ML Injection [Aukelso]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1.7 ML Aukelso 70 MG/ML Injection; Aukelso 120 MG in 1.7 ML Injection; Aukelso 120 MG per 1.7 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Denosumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Denosumab works by blocking a protein in your body that signals bone-dissolving cells to break down bone. By slowing that process, it helps your bones stay denser and stronger — wh...
  • What exactly does this injection do, and why do I need it?
  • You only need the injection once every 6 months — so just two visits a year. Between those visits, the most important thing you can do is take your calcium and vitamin D every sing...
  • How often do I have to come in for the shot, and what do I need to do between visits?
📖 Read our full Denosumab Injection guide →

🕸️ Concept Web — How 1.7 ML denosumab-kyqq 70 MG/ML Injection [Aukels... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1.7 ML denosumab-kyqq 70 MG/ML Injection [Aukelso] RxCUI 2725946

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Denosumab 993449
    • Denosumab-kyqq 2725924
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Aukelso 2725941
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Denosumab Injection 1655915
    • Denosumab-kyqq Injection 2725938
    • Denosumab Injectable Product 1157742
    • Denosumab-kyqq Injectable Product 2725926
    • Denosumab Injection [Aukelso] 2725944
    • Denosumab-kyqq Injection [Aukelso] 2725945
    • Aukelso Injectable Product 2725943
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1.7 ML denosumab-kyqq 70 MG/ML Injection SCD · 2725939
  • Denosumab-kyqq 70 MG/ML SCDC · 2725937
  • Denosumab Injection SCDF · 1655915
  • Denosumab-kyqq Injection SCDFP · 2725938
  • Denosumab Injectable Product SCDG · 1157742
  • Denosumab-kyqq Injectable Product SCDGP · 2725926

Brand-Name Concepts

  • Denosumab-kyqq 70 MG/ML [Aukelso] SBDC · 2725942
  • Denosumab Injection [Aukelso] SBDF · 2725944
  • Denosumab-kyqq Injection [Aukelso] SBDFP · 2725945
  • Aukelso Injectable Product SBDG · 2725943
  • Aukelso BN · 2725941

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2725946 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83257-0030-11 1 VIAL, SINGLE-USE in 1 CARTON (83257-030-11) / 1.7 mL in 1... AUKELSO Biocon Biologics Inc. 2026-01-05
Observed labelers: Biocon Biologics Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.